EUVIMEDEUVIMED entdecken
VergleichsstudieRandomisierte kontrollierte StudieOpen Access · CC BY 4.0

Comparative membrane incorporation of omega-3 fish oil triglyceride preparations differing by degree of re-esterification: A sixteen-week randomized intervention trial

Scott T Minton iD, Anthony L Almada, Joseph L Evans, Maggie Laidlaw, Joar Opheim

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0265462 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift PLOS ONE, 2023. Verfasst von Scott T Minton und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research, Nordic Naturals, Inc., Watsonville, California, United States of America. Hauptthemen laut MEDLINE: Fatty Acids, Omega-3, Fish Oils. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nordic Naturals, Inc..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Fish oil is routinely concentrated into unmodified triglycerides, or trans-esterified into an ethyl ester form. Re-esterification of the ethyl ester form yields re-esterified triglycerides (rTG), which are reportedly more bioavailable than ethyl ester forms. However, the fidelity of the re-esterification process may yield variable triglyceride forms, with only 55–60% being rTG.

Objective

To determine whether the blood lipidomic response to supplementation with two rTG supplements, varying by degree of re-esterification, would differ between treatments.

Design

This was a double-blind, parallel-design, single-center, 128-day study with sixty young, healthy subjects randomized into two groups. One group received a >95% rTG (Ultimate Omega®), as 1,000 mg capsules containing 325 mg eicosapentaenoic acid (EPA) and 225 mg docosahexaenoic acid (DHA), and the other received a

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fatty Acids, Omega-3Fish OilsArachidonic AcidCapsulesDietary SupplementsDocosahexaenoic AcidsEicosapentaenoic AcidEsterificationEstersFatty AcidsPhospholipidsTriglyceridesHumans

Substanzen

Arachidonic AcidCapsulesDocosahexaenoic AcidsEicosapentaenoic AcidEstersFatty AcidsFatty Acids, Omega-3fish oil triglyceridesFish OilsPhospholipids

Autor:innen und Institutionen

  • Department of Research, Nordic Naturals, Inc., Watsonville, California, United States of America.
  • Vitargo Global Sciences, Inc., Dana Point, California, United States of America.
  • P and N Development Ventures, Saint Louis, Missouri, United States of America.
  • Nutrasource Diagnostics Inc., Guelph, Ontario, Canada.

ORCID-Profile: Scott T Minton

Förderung

  • Nordic Naturals, Inc.

Zitieren

APA

Minton, S. T., Almada, A. L., Evans, J. L., Laidlaw, M., & Opheim, J. (2023). Comparative membrane incorporation of omega-3 fish oil triglyceride preparations differing by degree of re-esterification: A sixteen-week randomized intervention trial. PLOS ONE. https://doi.org/10.1371/journal.pone.0265462

Vancouver

Minton ST, Almada AL, Evans JL, Laidlaw M, Opheim J. Comparative membrane incorporation of omega-3 fish oil triglyceride preparations differing by degree of re-esterification: A sixteen-week randomized intervention trial. PLOS ONE. 2023. doi:10.1371/journal.pone.0265462

BibTeX
@article{Minton2023,
  author = {Minton, Scott T and Almada, Anthony L and Evans, Joseph L and Laidlaw, Maggie and Opheim, Joar},
  title = {Comparative membrane incorporation of omega-3 fish oil triglyceride preparations differing by degree of re-esterification: A sixteen-week randomized intervention trial},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0265462}
}
Kostenlos starten →